Catalyst Wire Dossier Catalyst Wire Dossier

EXE844 Otic Suspension

EXE844 · Alcon Research
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EXE844 Otic Suspension, covering 2017-07-12 to 2017-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2 [Phase 3]

See pricing